Clinica
Varian plans $250m share buy-back
30 August 2011
Madeleine Armstrong
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- Quarterly results round-up: good quarter for Varian, while Zimmer earnings growth gives cause for concern
- Quarterly results round-up: Illumina better than expected, Thermo Fisher raises guidance
- Quarterly results round-up: Bard and Zimmer in line, while Grifols stays strong
- AngioDynamics sees double with Navilyst buy
Other Informa News
EVENTS
